HAEM5:Volunteer Assignments and Opportunities: Difference between revisions
| [unchecked revision] | [unchecked revision] |
No edit summary |
No edit summary |
||
| Line 33: | Line 33: | ||
|Jack Reid, MD (University of California, Irvine) Mark Evans, MD (University of California, Irvine) Fabiola Quintero-Rivera, MD (University of California, Irvine) | |Jack Reid, MD (University of California, Irvine) Mark Evans, MD (University of California, Irvine) Fabiola Quintero-Rivera, MD (University of California, Irvine) | ||
|- | |- | ||
|Chronic neutrophilic leukaemia||Disease||Anamaria Munteanu, MD, Ph.D**, Harbor-UCLA Medical Center, Joseph J. Merlo Jr, MD. Ph.D**, Ashion Analytics, Fabiola Quintero-Rivera, University of California Irvine <nowiki>**</nowiki>contributed equally | |Chronic neutrophilic leukaemia||Disease|| || || || || ||FQR|| || | ||
|Chronic Neutrophilic Leukemia (CNL) | |||
|Anamaria Munteanu, MD, Ph.D**, Harbor-UCLA Medical Center, Joseph J. Merlo Jr, MD. Ph.D**, Ashion Analytics, Fabiola Quintero-Rivera, University of California Irvine <nowiki>**</nowiki>contributed equally | |||
|- | |- | ||
|Chronic eosinophilic leukaemia||Disease|| | |Chronic eosinophilic leukaemia||Disease|| || || || || ||FQR|| || | ||
| | |Chronic Eosinophilic Leukemia, Not Otherwise Specified | ||
| | |Chelsea D. Kramish; Daynna J.Wolff | ||
|- | |- | ||
|Polycythaemia vera||Disease|| | |Polycythaemia vera||Disease|| || || || || ||FQR|| || | ||
| | |Polycythemia Vera (PV) | ||
| | |Gokce A. Toruner, MD, PhD UT MD Anderson Cancer Center | ||
|- | |- | ||
|Essential thrombocythaemia||Disease||Rebecca Smith, PhD, Director, Genetics Associates, Nashville, TN|| || || || ||FQR|| || | |Essential thrombocythaemia||Disease||Rebecca Smith, PhD, Director, Genetics Associates, Nashville, TN|| || || || ||FQR|| || | ||
| | |Essential Thrombocythemia (ET) | ||
| | | | ||
|- | |- | ||